We are part of Cencora.
Cencora brings AmerisourceBergen and all of our companies and services together under one new name. While we are expanding our network of like-minded pharmacists, physicians, caregivers and healthcare continuum, our commitment to supporting your ability to provide patient-centric care has never been more of a focus. It’s business as usual while our full transition unfolds over time.
Empowering community oncology to advance patient care
We help community oncology practices thrive
As the longest-standing oncology-specific GPO and physician service organization, the AmerisourceBergen Specialty GPOs' ION Oncology Practice Network is the preferred strategic partner for community oncology practices nationwide.
With over 20 years of experience, you can rely on us for more than GPO contracts. In addition to giving you access to the most advanced therapies at competitive contract rates, our experts take pride in helping member practices tap the potential within their business. Whether you're interested in uncovering new clinical and operational efficiencies, opening new lines of revenue, or need support navigating the transition to value-based reimbursement—we'll be there to help you, every step of the way.
July 23, 2024 | 11:00 AM CT/12:00 PM EST | Virtual
A Webcast presented on behalf of AbbVie
Topic: A Path Forward in Managing Newly Diagnosed AML, Examining the Efficacy and Safety of VENCLEXTA-based regimes.
Learning Objective:
Explore treatment options with VENCLEXTA regimens for your appropriate newly diagnosed patients with AML, regardless of mutations status.
Review the phase 3 efficacy and safety outcomes from the pivotal VIALE-A study, including VIALE-A long-term follow-up data.
Discuss how to dose and administer VENCLEXTA for appropriate patients with newly diagnosed AML.
Speaker:
Thomas LeBlanc, MD
Associate Professor of Medicine in the Duke University School of Medicine and a member of the Duke Cancer Institute
**You must be a registered participant to receive the web and dial in instructions**
July 9, 2024 | 12:00PM CT/1:00PM ET | Virtual
A Webcast presented on behalf of AstraZeneca
Topic: Treatment of Unresectable Stage III NSCLC
Learning Objective: This presentation highlights clinical trial evidence in unresectable Stage III NSCLC. You can expect an overview of efficacy and safety data, key takeaways, a patient case study, and information about support programs.
Speaker:
Speaker: Jack Erter, MD, MMHC
**You must be a registered participant to receive the web and dial in instructions**
.jpg?h=5324&iar=0&w=7212&hash=2F4153260EAA4B1FE4A239BED57FF097)
July 25, 2024 | 12:00-12:30 pm ET | Virtual
GPO 101: Service partner opportunities
You are invited to join us for the fourth session in our GPO 101 series focused on giving you an overview of everything involved with being a member of a GPO. This session will cover the opportunities available through our service partners and how to integrate these solutions into your practice.
Speakers
Bruce Heintzman, Sr. Director, Business Development Operations, Cencora
Charley Deckers, VP, Business Development and Alliances, Cencora
Attendees will have the opportunity to submit questions for a Q&A at the end of the session.
June 25, 2024 | 11:00am CT/12:00pm ET | Virtual
A Webcast presented on behalf of Bayer
Topic: Exploring The Role of Nubeqa (darolutamide) in mHSPC in Combination with Docetaxel & in nmCRPC Including mHSPC & nmCRPC Case Studies.
Objectives:
- Prostate Cancer Overview
- Nubeqa Background & Guidelines
- mHSPC Data & Case Study
- nmCRPC Data & Case Study
- Dosing
- DDI’s
- Coverage
- Support & Summary
Speaker:
Dr. Aaron Berger
Board-Certified Urologist
Chief Medical Officer & Director of Clinical Research
Associated Urological Surgeons
Global Provider Insights Network® (GPIN)
Participate in honoraria-based market research
Bring your expertise to a network of over 1,500 healthcare professionals with GPIN. Your clinical experience is vital in guiding manufacturers to better meet the needs of healthcare providers and patients, leading to improved treatment options.
Begin by completing a short questionnaire, which marks your first step in sharing insights that contribute to the progression of patient care. For your valuable input and time, you will receive an honorarium based on fair market value.
OnCall
Biosimilar Basics: Payer Perspective
In this episode, the fourth of our Biosimilars series, Christie Smith discusses the biosimilar payer perspective.
If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCallGPO@gmail.com.
Technology and insights to elevate your practice
Experience our commitment to digital innovation with AB GPOconnect
AB GPOconnect provides you with a comprehensive view and direct access to the information needed to make sound strategic decisions, in addition to better forecasting and cash flow predictions. The data you need to support your business is now online and available on demand 24/7.
Key features
- The GPO Scorecard allows you to closely monitor your quarterly performance on contracted rebate and OID opportunities.
- The self-service Rebate Payment Tracker gives visibility into past and upcoming rebates, allowing for easy tracking and status updates.
- The GPO Value Report helps quantify the value of your GPO membership and more accurately predict cashflow.
We help you focus on what matters most—
patient care
Optimize access and purchasing power
Navigate industry changes
Advance the quality of patient care
Your Smart GPO
What does it mean to be a Smart GPO? For us, it means using data and actionable insights to support your practice in the transition to value-based care. It means providing analytics tools to help you align with national guidelines. And it means using empirical evidence to put patient outcomes at the heart of your practice's health and sustainability.
When you join our Smart GPO, you become part of a network of community oncology practices making data-backed decisions to advance the quality of patient care. That's having a smart partner in your corner.
.png)
InfoDive®
Powering better business performance
What you don't know can hurt your business. With InfoDive, our business intelligence tool, you can go beneath the surface of your data to reveal profound insights and opportunities. By combing through your EHR, PM and inventory management data, InfoDive identifies operational efficiencies in administrative workflows and assesses gaps in financial reconciliation—helping ensure you're never leaving revenue behind.
If you're ready to streamline operations, recover lost revenue and reduce your audit risk, you're ready for InfoDive.